Rigel Pharmaceuticals, Inc. (RIGL) quarterly cash flow statement — complete operating, investing & financing history
Rigel Pharmaceuticals, Inc. (RIGL) cash flow statement — 27-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | 30.65M | 2.73M | 21.98M | 24.03M | 30.54M | -893K | 14.5M | 21.68M | 302K | -5.01M | -6.24M | -1.36M | 5.93M | -4.07M | -21.91M | -13.3M | -12.91M | -25.64M | -19.09M | -10.3M |
| Operating CF Margin % | 38.95% | 4.63% | 31.49% | 34.6% | 30.03% | -1.67% | 25.18% | 39.2% | 0.82% | -16.97% | -17.43% | -4.83% | 22.06% | -15.63% | -42.73% | -59.35% | -43.3% | -153.19% | -93.52% | -47.8% |
| Operating CF Growth % | 0.38% | 405.15% | 51.55% | 10.85% | 10011.59% | 82.19% | 332.42% | 1695.22% | -94.91% | -23.05% | 71.52% | 89.78% | 145.93% | 84.11% | -14.79% | -29.17% | -123.38% | -28.47% | -22.57% | 47.15% |
| Net Income | 17.29M | 8.65M | 268.06M | 27.9M | 59.61M | 11.45M | 14.34M | 12.42M | -1.03M | -8.25M | 737K | -5.69M | -6.6M | -13.54M | 1.4M | -19.04M | -13.49M | -27.45M | -22.64M | -20.95M |
| Depreciation & Amortization | 848K | 597K | 601K | 603K | 607K | 604K | 604K | 611K | 613K | 400K | 293K | 292K | 296K | 357K | 284K | 240K | 237K | 237K | 404K | 261K |
| Stock-Based Compensation | 6.84M | 3.46M | 2.75M | 3.36M | 3.28M | 3.32M | 2.09M | 2.64M | 2.53M | 5.13M | 1.93M | 1.94M | 2.17M | 2.76M | 4.08M | 2.71M | 2.39M | 3.21M | 2.34M | 2.2M |
| Deferred Taxes | 5.21M | 2.57M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -11.12M | -170K | -246.09M | -467K | -40.23M | -190K | -332K | -92K | -159K | -205K | -370K | -127K | 5K | 279K | 148K | -203K | -174K | 710K | 941K | 962K |
| Working Capital Changes | 11.58M | -12.38M | -3.34M | -7.37M | 7.27M | -16.08M | -2.2M | 6.09M | -1.65M | -2.1M | -8.83M | 2.23M | 10.06M | 6.07M | -27.82M | 2.99M | -1.87M | -2.35M | -129K | 7.23M |
| Change in Receivables | -6.1M | 1.82M | -5.84M | -6.02M | 1.64M | 68K | -11.04M | -1.67M | -1.39M | 3.04M | -7M | -2.73M | 8.55M | 10.95M | -24.8M | 1.67M | -1.96M | 232K | -481K | 2.38M |
| Change in Inventory | -3.26M | -581K | 1.13M | 188K | -8.37M | 1.41M | 1.93M | 3.34M | -2.19M | -2.31M | 2.53M | 281K | 309K | -1.95M | -1.98M | -877K | 595K | -112K | 450K | -167K |
| Change in Payables | -475K | -2.71M | 3.35M | -3.44M | 3.34M | 615K | -476K | -2.31M | -3.15M | 2.13M | -857K | 2.76M | -1.05M | -1.21M | 4.79M | 586K | -2.44M | 850K | 697K | 1.37M |
| Cash from Investing | 17.45M | -7.97M | -25.36M | -33.17M | -23.28M | -10.55M | -10.91M | 3.8M | 10.93M | 313K | -6.87M | -1.17M | 2.97M | 777K | 18.6M | 10.46M | 21.09M | 22.63M | 6.49M | -44.4M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -26K | -10K | -222K | -138K | 0 | 0 | 0 | -15M | -73K | -189K | 36K | -224K | 0 | -170K |
| CapEx % of Revenue | - | - | - | - | - | - | 0.05% | 0.02% | 0.6% | 0.47% | - | - | - | 57.54% | 0.14% | 0.84% | 0.12% | 1.34% | - | 0.79% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 264K | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -70.35M | 0 | 12K | -12K | 0 | 0 | 72K | 26K | 0 | 0 | 110K | 22K | 0 | 127K | 350K | 279K | 264K | 0 | 21K | 0 |
| Cash from Financing | -11.7M | -10.92M | -4.57M | 4.27M | 418K | 484K | 1.47M | -9.84M | -752K | -2.51M | 486K | -869K | -373K | 19.12M | -2.1M | 5.51M | -5.66M | 8.8M | 1.08M | 274K |
| Debt Issued (Net) | -7.75M | -7.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.95M | 0 | 9.6M | -33K | 9.97M | 0 | 0 |
| Equity Issued (Net) | 5.6M | -3.42M | 2.93M | 4.27M | 418K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 599K | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 3.74M | -3.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -9.55M | 0 | -7.5M | 0 | 0 | 484K | 1.47M | -9.84M | -752K | -2.51M | 486K | -869K | -373K | -827K | -2.1M | -4.09M | -6.23M | -1.18M | 1.08M | 274K |
| Net Change in Cash | 36.41M | -16.17M | -7.95M | -4.87M | 7.68M | -10.96M | 5.05M | 15.64M | 10.48M | -7.21M | -12.63M | -3.4M | 8.53M | 15.83M | -5.41M | 2.67M | 2.52M | 5.79M | -11.51M | -54.42M |
| Free Cash Flow | 30.65M | 2.73M | 21.99M | 24.02M | 30.54M | -893K | 14.48M | 21.67M | 80K | -5.15M | -6.24M | -1.36M | 5.93M | -19.07M | -21.98M | -13.49M | -12.88M | -25.86M | -19.07M | -10.47M |
| FCF Margin % | 38.95% | 4.63% | 31.51% | 34.58% | 30.03% | -1.67% | 25.14% | 39.18% | 0.22% | -17.44% | -17.43% | -4.83% | 22.06% | -73.16% | -42.87% | -60.2% | -43.18% | -154.53% | -93.41% | -48.59% |
| FCF Growth % | 0.38% | 405.15% | 51.91% | 10.85% | 38071.25% | 82.66% | 332% | 1694.48% | -98.65% | 72.99% | 71.61% | 89.93% | 146.06% | 26.24% | -15.3% | -28.88% | -123.49% | -29.14% | -18.59% | 46.81% |
| FCF per Share | 1.57 | 0.14 | 1.17 | 1.25 | 1.68 | -0.05 | 0.80 | 1.23 | 0.00 | -0.29 | -0.36 | -0.08 | 0.34 | -1.10 | -1.27 | -0.78 | -0.75 | -1.51 | -1.11 | -0.61 |
| FCF Conversion (FCF/Net Income) | 1.77x | 0.31x | 0.08x | 0.86x | 0.51x | -0.08x | 1.01x | 1.75x | -0.29x | 0.61x | -8.47x | 0.24x | -0.90x | 0.30x | -15.64x | 0.70x | 0.96x | 0.93x | 0.84x | 0.49x |
| Interest Paid | -1.32M | 1.32M | 1.56M | 1.68M | 1.68M | 1.65M | 1.75M | 1.83M | 1.77M | 1.68M | 1.68M | 1.68M | 1.47M | 1.01M | 946K | 598K | 0 | 393K | 406K | 371K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |